Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Invested Capital (2020 - 2026)

Rani Therapeutics Holdings' Invested Capital history spans 7 years, with the latest figure at $35.5 million for Q1 2026.

  • On a quarterly basis, Invested Capital rose 268.28% to $35.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was $35.5 million, a 268.28% increase, with the full-year FY2025 number at $41.5 million, up 124.47% from a year prior.
  • Invested Capital came in at $35.5 million for Q1 2026, down from $41.5 million in the prior quarter.
  • The five-year high for Invested Capital was $110.8 million in Q1 2022, with the low at $5.7 million in Q3 2025.
  • Historically, Invested Capital has averaged $42.6 million across 5 years, with a median of $35.5 million in 2026.
  • Biggest five-year swings in Invested Capital: crashed 72.37% in 2025 and later soared 268.28% in 2026.
  • Year by year, Invested Capital stood at $74.0 million in 2022, then plummeted by 59.0% to $30.3 million in 2023, then plummeted by 39.05% to $18.5 million in 2024, then skyrocketed by 124.47% to $41.5 million in 2025, then fell by 14.38% to $35.5 million in 2026.
  • Business Quant data shows Invested Capital for RANI at $35.5 million in Q1 2026, $41.5 million in Q4 2025, and $5.7 million in Q3 2025.